Rani Therapeutics Raises Series C For Robotic Pill
San Jose-based Rani Therapeutics, a developer of a "robotic pill" for delivering drugs orally to patients, has raised a Series C funding round, the company said Tuesday. Size of the funding round was not announced. The funding came from Novartis, Google Ventures, InCube Ventures, and VentureHealth, along with others. Rani is led by Mir Imran. The deal comes along with a collaboration partnership with Novartis.
posted on Wednesday, May 27, 2015
Related companies:
Rani Therapeutics, LLC
Related stories:
> Emerald Therapeutics Raises $13.5M For Robotic Wet Labs
> CytomX Therapeutics Raises $41M
> Arete Therapeutics Raises $35M
> Nuon Therapeutics Raises $27M
> Horizon Therapeutics Raises $15M
silicontap.com Home